Patents for C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428) |
---|
04/14/2004 | EP1406896A1 Atereoselective method for the preparation of nucleoside analogues |
04/14/2004 | CN1145622C Substitated benzo heterocyclic compounds, process for their preparation and pharmaceutical compositions containing same |
04/14/2004 | CN1145621C Aromatic cyclic polyketone oligomer and its preparing method |
04/06/2004 | US6716881 Carbanilides used as pesticides |
04/06/2004 | CA2067381C Treatment of hiv infections and compounds useful therein |
04/01/2004 | WO2003104199A3 Iminium salts in cleaning compositions |
04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
04/01/2004 | US20040063669 Alpha-phenyl-beta-ketosulfone |
03/18/2004 | US20040054010 Endosulfan (6,7,8,9,10,10-hexachloro-1,5, 5a,6,9,9a-hexahydro-6,9-methano-2,4,3-benzodioxathiepin-3-oxid e) as active ingredient in controlling pest infestation in agriculture |
03/11/2004 | US20040048852 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
03/10/2004 | CN1141305C Manufacture of 1, 3-oxathiolane nucleosides |
03/09/2004 | US6703396 Cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl) -(1h)-pyrimidin-2-one |
03/04/2004 | WO2004018410A1 Substituted benzanilide compound and pest control agent |
02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
02/26/2004 | US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
02/26/2004 | US20040038350 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner |
02/25/2004 | CN1139586C Process for stereoselective preparation of hetero-bicyclic alcohol enantiomer |
02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
02/17/2004 | US6692975 Compounds for use in the detection of preferential particles in sample |
02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
02/11/2004 | CN1474650A Improved endosulfan formulation and methods of use thereof |
02/05/2004 | DE10232094A1 5-Thiaepothilone und 15-disubstituierte Epothilone 5-Thiaepothilone and 15-disubstituted epothilones |
02/04/2004 | CN1137095C Preparation of i(N)-substituted-hydroxycycloalkylamine derivatives |
01/29/2004 | WO2003040080A3 Lipoxin a4 analogs |
01/29/2004 | US20040018951 Organic catalyst with enhanced solubility |
01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
01/22/2004 | WO2004007492A1 Novel macrocycles for the treatment of cancer |
01/22/2004 | WO2004007483A1 Novel macrocycles for the treatment of cancer diseases |
01/22/2004 | WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf) |
01/22/2004 | CA2491422A1 Novel macrocycles for the treatment of cancer diseases |
01/21/2004 | CN1469743A 雌激素受体调节剂 Estrogen receptor modulators |
01/13/2004 | US6677374 Nervous system disorders |
12/30/2003 | US6670385 α-phenyl-βketosulfone |
12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
12/18/2003 | WO2003104199A2 Organic catayst with enhanced solubility |
12/18/2003 | US20030232807 Dietetic agents |
12/18/2003 | CA2485164A1 Organic catalyst with enhanced solubility |
12/17/2003 | EP1370547A1 Benzoaxathiepin derivatives and their use as medicines |
12/11/2003 | US20030229073 Tricyclic compounds and method of treating herpes virus |
12/04/2003 | WO2003099804A1 Oxathiincarboxamides |
12/04/2003 | US20030225132 Heterocyclic salts such as 3-(3-Hydroxyphenyl)-2-(4-(2-(1-pyrrolidinium)ethoxyphenol)-2,3-dihydro-1,4 -benzoxathiin-6-ol hydrochloride salt, used as estrane agonists, for phrophylaxis of bone disorders |
12/04/2003 | US20030224290 S-acylmethyl-S,S-oxydiethylenesulfonium salt in which the acyl is substituted by hydrocarbyl, hydrocarbyloxy or hydrocarbylamino; photoacid generator for high resolution for high energy rays of 300 nm or less |
11/18/2003 | US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
11/12/2003 | EP1361223A1 Method of manufacture of 1,3-oxathiolane nucleosides |
11/12/2003 | EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
11/11/2003 | CA2112258C Chiral phospholanes via chiral 1,4-diol cyclic sulfates |
11/06/2003 | WO2003091239A1 Estrogen receptor modulators |
11/04/2003 | US6642251 Antitumor, 2-indolinone derivatives |
11/04/2003 | US6642245 Treatment of HIV and HBV infections in humans |
10/23/2003 | WO2003087073A1 Estrogen receptor modulators |
10/23/2003 | WO2003086388A1 Estrogen receptor modulators |
10/23/2003 | WO2003043960A3 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6 |
10/23/2003 | US20030199570 Phenyl substituted thiophenes as estrogenic agents |
10/23/2003 | US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
10/21/2003 | US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
10/21/2003 | CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
10/15/2003 | CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
10/15/2003 | CN1124273C Fluoric diphenylacetylene compounds and preparing process and application thereof |
10/14/2003 | US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like |
10/14/2003 | US6632807 (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide |
10/14/2003 | CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors |
10/08/2003 | CN1123566C Arylsulfonyl hydroxamic acid derivatives |
10/01/2003 | EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
09/25/2003 | WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient |
09/25/2003 | CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient |
09/24/2003 | CN1444564A Biphenyl carboxamides |
09/24/2003 | CN1443762A Method for synthesizing aromatic cyclic oligomer |
09/23/2003 | US6624189 Byrostatin analogues, synthetic methods and uses |
09/18/2003 | WO2002102796A8 Stereoselective method for the preparation of nucleoside analogues |
09/18/2003 | US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
09/17/2003 | EP1343373A1 Improved endosulfan formulation and methods of use thereof |
09/17/2003 | CN1121401C Aminophenol derivates |
09/16/2003 | CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
09/12/2003 | WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides |
09/10/2003 | EP0983236B1 Process for the preparation of an oxirane, aziridine or cyclopropane |
09/03/2003 | EP1340752A1 Process for the production of semi synthetic statins via novel intermediates |
08/26/2003 | US6610747 Phenoxybenzylamine derivatives as SSRIs |
08/13/2003 | EP1333827A2 Estrogen receptor modulators |
08/12/2003 | US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
08/07/2003 | US20030149031 For therapy of inflammation |
08/05/2003 | US6602903 Substituted heterocyclic compounds |
07/31/2003 | WO2003061651A1 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
07/31/2003 | US20030144532 Method of manufacture of 1,3-oxathiolane nucleosides |
07/24/2003 | US20030139376 Lipoxin A4 analogs |
07/23/2003 | EP1328522A2 Estrogen receptor modulators |
07/17/2003 | US20030135051 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors |
07/17/2003 | US20030135048 Predominantly cis nucleosides or nucleoside analogues and derivatives from 2-oxymethyl- thiolane-S-oxide, oxathiolane-S-oxide or dithiolane-S-oxide and a pyridine, pyrimidine or triazine base |
06/26/2003 | WO2003051865A1 Dioxathianones |
06/25/2003 | CN1425662A Bucillamine synthesizing novel intermediate 5,5-dimethyl-2-thione-4-one-1-sulfur-3-oxy-hetero pentocyclic |
06/24/2003 | US6583161 Benzenesulfonamides and benzamides as therapeutic agents |
06/10/2003 | US6576776 Method of manufacture of 1,3-oxathiolane nucleosides |
06/05/2003 | US20030105375 An ion-containing compound is admixed with macromolecular crown ether or derivatives to form an extractant/ion complex, and the predetermined extractant/ion complex is separated from the diluent by using the new phase affinity |
06/05/2003 | US20030105062 Anti-bacterial agents based upon oxoanion binding |
06/04/2003 | EP1114027B1 The preparation of n-substituted-hydroxycycloalkylamine derivatives |
05/30/2003 | WO2003043960A2 IMPROVED PURIFICATION OF 4, 4'(5')-DI-t-BUTYLCYCLOHEXANO-18-CROWN-6 |
05/28/2003 | EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
05/21/2003 | CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph |
05/21/2003 | CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners |
05/21/2003 | CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |